COMMUNIQUÉS West-GlobeNewswire

Oncotelic Therapeutics Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients
17/07/2025
Data support further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma (PDAC). AGOURA HILLS, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- [...]
AI-Supported, Single-Center Cancer Model from Liv Hospital
17/07/2025
Photo: Liv Hospital via FL Communications ISTANBUL, July 17, 2025 (GLOBE NEWSWIRE) -- The “single-center oncology model,” implemented by only a select number of institutions worldwide, is being carried out with advanced [...]
Professional Credit Renews HFMA Peer Review Designation
17/07/2025
CHICAGO, July 17, 2025 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) today announced that, following rigorous review, Professional Credit has once again achieved the “Peer Reviewed by HFMA [...]
SPR to Feature Five Abstracts on SPRINT® PNS at ASPN 2025
17/07/2025
- Data on chronic postoperative knee pain to be highlighted as a top abstract along with a first-ever look at SPRINT PNS in patients with migraine pain - CLEVELAND, July 17, 2025 (GLOBE NEWSWIRE) -- Leading pain [...]
Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within Reach
17/07/2025
FY25 revenue up 14.3% YOY FY25 margins improvement of 8.9% to 76.6%, from 69.3% in the prior year; Q4-FY25 margins improved to 80.4% as margin expansion forecasted to continue FY25 operating expenses lower by 24.5% YOY [...]
Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility
17/07/2025
WARREN, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) today announced the signing of a letter of intent to lease a 17,428-square-foot facility in New Jersey. [...]
Creative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune Cells
17/07/2025
PHOENIX, July 17, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”) , a clinical-stage biotechnology company specializing in regenerative medicine, [...]
Philips Launches ECG AI Marketplace to Enhance Early Cardiac Diagnosis
17/07/2025
July 17, 2025 Anumana's FDA-cleared LEF algorithm becomes first certified third-party solution available through Philips’ ECG ecosystem CAMBRIDGE, Mass. — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health [...]
Adventure Awaits: Make-A-Wish® Central and Northern Florida Makes Jeremy’s Dream Come True with a Thrilling Mexican Sport Fishing Adventure
17/07/2025
Family to Embark on an Unforgettable Trip, Courtesy of Stan and Naomi Loomis ORLANDO, Fla., July 17, 2025 (GLOBE NEWSWIRE) -- Make-A-Wish® Central and Northern Florida , in collaboration with Stan and Naomi Loomis, co- [...]
Connect Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
17/07/2025
SAN DIEGO, July 17, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the [...]
OKYO Pharma Receives $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain
17/07/2025
LONDON and NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO ), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an [...]
RadNet’s Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of iCAD
17/07/2025
Acquisition contributes iCAD's commercial, technology, and regulatory capabilities The acquisition positions DeepHealth with an industry-leading suite of AI-powered breast cancer image interpretation and workflow [...]
Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies
17/07/2025
SEATTLE, July 17, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, LLC, an innovative subsidiary of Fifty 1 Labs, Inc. ( OTC: FITY ), is thrilled to announce a strategic partnership with an intent to acquire BioSpark [...]
Tria Federal Expands VA Partnership with $174M Software Engineering & Development Award
17/07/2025
ARLINGTON, Va., July 17, 2025 (GLOBE NEWSWIRE) -- Tria Federal has received a $174 million contract award to provide expanded software engineering and development services to the Department of Veterans Affairs’ (VA) [...]
Actuate Therapeutics Advances Clinical Program in Ewing Sarcoma After Positive Phase 1 Trial Demonstrates Complete and Partial Responses in Difficult-to-Treat Pediatric Sarcomas
17/07/2025
- Announces Completion of Phase 1 Study of Elraglusib in Pediatric Patients - Prolonged and Durable Complete Responses (CRs) Observed in Two of Ten Refractory Ewing Sarcoma Patients - Two Additional Patients Had Durable [...]
Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock
17/07/2025
Led by Strategic Industry Partner and Select Institutional Investors Proceeds Strengthen Balance Sheet and Support Commercialization of Innovation Strategy ST. LOUIS, July 17, 2025 (GLOBE NEWSWIRE) -- Stereotaxis, Inc [...]
Vor Bio Appoints Qing Zuraw, M.D. as Chief Development Officer
17/07/2025
Dr. Zuraw led clinical development of telitacicept across MG, Sjögren’s, SLE, and RA at RemeGen, resulting in multiple regulatory approvals in China ; brings deep U.S. and global development experience to support Vor [...]
Neurogen Biomarking to present novel data on at-home p-tau 217 testing for Alzheimer’s disease at Alzheimer’s Association International Conference® 2025
17/07/2025
CHICAGO, July 17, 2025 (GLOBE NEWSWIRE) -- Neurogen Biomarking will present novel data on at-home p-tau 217 testing for Alzheimer’s disease at the upcoming Alzheimer’s Association International Conference® (AAIC) in [...]
BioNTech Announces Ryan Richardson to Step Down from the Management Board
17/07/2025
MAINZ, Germany, July 17, 2025 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that Ryan Richardson will step down as Chief Strategy Officer in the Management Board of BioNTech [...]

Pages